E-resources
Peer reviewed
-
Holcomb, John B; Moore, Ernest E; Sperry, Jason L; Jansen, Jan O; Schreiber, Martin A; del Junco, Deborah J; Spinella, Philip C; Sauaia, Angela; Brohi, Karim; Bulger, Eileen M; Cap, Andrew P; Hess, John R; Jenkins, Donald; Lewis, Roger; Neal, Matthew D; Newgard, Craig; Pati, Shibani; Pusateri, Anthony E; Rizoli, Sandro; Russell, Robert T; Shackelford, Stacy A; Stein, Deborah M; Steiner, Marie; Wang, Henry; Ward, Kevin R; Young, Pampee
Annals of surgery, 03/2021, Volume: 273, Issue: 3Journal Article
OBJECTIVE:To address the clinical and regulatory challenges of optimal primary endpoints for bleeding patients by developing consensus-based recommendations for primary clinical outcomes for pivotal trials in patients within six categories of significant bleeding, 1) traumatic injury, 2) intracranial hemorrhage, 3) cardiac surgery, 4)gastrointestinal hemorrhage, 5) inherited bleeding disorders and 6) hypoproliferative thrombocytopenia. BACKGROUND:A standardized primary outcome in clinical trials evaluating hemostatic products and strategies for the treatment of clinically significant bleeding will facilitate the conduct, interpretation, and translation into clinical practice of hemostasis research and support alignment among funders, investigators, clinicians, and regulators. METHODS:An international panel of experts was convened by the National Heart Lung and Blood Institute and the United States Department of Defense on September 23rd and 24th 2019. For patients suffering hemorrhagic shock, the 26 trauma working-group members met for almost a year, utilizing biweekly phone conferences and then an in-person meeting, evaluating the strengths and weaknesses of previous high quality studies. The selection of the recommended primary outcome was guided by goals of patient-centeredness, expected or demonstrated sensitivity to beneficial treatment effects, biologic plausibility, clinical and logistical feasibility, and broad applicability. CONCLUSIONS:For patients suffering hemorrhagic shock, and especially from truncal hemorrhage, the recommended primary outcome was 3 to 6 hour all-cause mortality, chosen to coincide with the physiology of hemorrhagic death and to avoid bias from competing risks. Particular attention was recommended to injury and treatment time, as well as robust assessments of multiple safety related outcomes.
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.